Since blocking FSH was reported to reduce body fat in mice [18], we next determined whether obesity was involved in the potential negative role of circulating FSH on the risk of NAFLD by further adjusting for BMI and WC in model 2. The gene discussed is BRD2; the disease is metabolic dysfunction-associated steatotic liver disease.